- Home
- ENS vs IMVT Comparison
ENS vs IMVT Comparison
Compare ENS & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- IMVT
- Stock Information
- Founded
- ENS 1991
- IMVT N/A
- Country
- ENS United States
- IMVT United States
- Employees
- ENS N/A
- IMVT N/A
- Industry
- ENS Industrial Machinery/Components
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ENS Technology
- IMVT Health Care
- Exchange
- ENS Nasdaq
- IMVT Nasdaq
- Market Cap
- ENS 3.6B
- IMVT 3.6B
- IPO Year
- ENS N/A
- IMVT N/A
- Fundamental
- Price
- ENS $100.54
- IMVT $23.59
- Analyst Decision
- ENS Buy
- IMVT Strong Buy
- Analyst Count
- ENS 3
- IMVT 11
- Target Price
- ENS $117.50
- IMVT $46.11
- AVG Volume (30 Days)
- ENS 307.2K
- IMVT 1.1M
- Earning Date
- ENS 02-05-2025
- IMVT 02-10-2025
- Dividend Yield
- ENS 0.96%
- IMVT N/A
- EPS Growth
- ENS 20.93
- IMVT N/A
- EPS
- ENS 7.05
- IMVT N/A
- Revenue
- ENS $3,508,854,000.00
- IMVT N/A
- Revenue This Year
- ENS $4.14
- IMVT N/A
- Revenue Next Year
- ENS $2.82
- IMVT N/A
- P/E Ratio
- ENS $14.24
- IMVT N/A
- Revenue Growth
- ENS N/A
- IMVT N/A
- 52 Week Low
- ENS $86.41
- IMVT $22.41
- 52 Week High
- ENS $112.53
- IMVT $40.36
- Technical
- Relative Strength Index (RSI)
- ENS 67.25
- IMVT 39.44
- Support Level
- ENS $88.50
- IMVT $22.41
- Resistance Level
- ENS $95.36
- IMVT $25.29
- Average True Range (ATR)
- ENS 1.97
- IMVT 1.22
- MACD
- ENS 0.93
- IMVT 0.05
- Stochastic Oscillator
- ENS 96.24
- IMVT 34.91
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers worldwide. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).